Parkwalk manages a portfolio of investments in world-class university spin-outs
Parkwalk is a leading investor in ‘hard science’ companies: commercialising the scientific discoveries made at the UK’s globally-ranked research universities.
Parkwalk is the UK’s most active investor in the university spin-out sector, and currently has over £500m of assets under management. We have invested in over 180 companies across our managed funds, including funds managed in conjunction with the universities of Oxford, Cambridge, Imperial and Bristol.
In 2017 Parkwalk joined forces with IP Group plc, a FTSE 250 listed company.
-
Over 10 years’ experience investing in the distinct asset class of UK university spinouts
-
As a Group we have arrangements with some of the UK Russell Group Universities
-
Experienced team, with a track record of generating cash returns to investors
-
Parkwalk benefits from £1.2bn group resources but maintains investment independence
Parkwalk has invested in over 180 UK technology spin-outs. Over 2,000 patents protect their technology and processes, and the companies have raised in excess of £2.5bn of funding since 2010.
Parkwalk believes it has unparalleled access to some of the highest calibre innovation and IP generated within UK universities and research-intensive institutions through its strong position within the university commercialisation ecosystem and its relationships with university Technology Transfer Offices.
Alignment of interest
Parkwalk works closely with founders, university partners and our co-investors to optimise results for our investors and all stakeholders in our investee companies. We believe supporting this distinct asset class has the ability not only to generate attractive investment returns but also positive returns for UK plc, and broader society.
